These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8757567)
1. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. Al-Kharfy T; Smyth JA; Wadsworth L; Krystal G; Fitzgerald C; Davis J; Milner R J Pediatr; 1996 Jul; 129(1):89-96. PubMed ID: 8757567 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652 [TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. Yeo CL; Choo S; Ho LY J Paediatr Child Health; 2001 Aug; 37(4):352-8. PubMed ID: 11532054 [TBL] [Abstract][Full Text] [Related]
5. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Ohlsson A; Aher SM Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062 [TBL] [Abstract][Full Text] [Related]
6. Double blind trial of recombinant human erythropoietin in preterm infants. Emmerson AJ; Coles HJ; Stern CM; Pearson TC Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265 [TBL] [Abstract][Full Text] [Related]
7. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Carnielli VP; Da Riol R; Montini G Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624 [TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438 [TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human erythropoietin in infants with very low birth weights. Samanci N; Ovali F; Dagoglu J Int Med Res; 1996; 24(2):190-8. PubMed ID: 8737229 [TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns. Siddappa AM; Olson RM; Spector M; Northrop E; Zamora T; Brearley AM; Georgieff MK; Rao R J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933 [TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia. Ohls RK; Hunter DD; Christensen RD J Pediatr; 1993 Dec; 123(6):996-1000. PubMed ID: 8229537 [TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. Akisu M; Tuzun S; Arslanoglu S; Yalaz M; Kultursay N Acta Med Okayama; 2001 Dec; 55(6):357-62. PubMed ID: 11779098 [TBL] [Abstract][Full Text] [Related]
14. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. Ohls RK; Harcum J; Schibler KR; Christensen RD J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy. Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin in anemia of prematurity. Whitehall JS; Patole SK; Campbell P Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598 [TBL] [Abstract][Full Text] [Related]
18. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Aher SM; Ohlsson A Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of anemia of prematurity. Chen JY; Wu TS; Chanlai SP Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930 [TBL] [Abstract][Full Text] [Related]
20. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]